US approves cannabidiol to treat tuberous sclerosis complex seizures

The US Food and Drug Administration (FDA) has approved a cannabidiol (CBD) based medicine, Epidiolex, for treating seizures associated with tuberous sclerosis complex (TSC). Epidiolex has already been approved in the US for treating seizures caused by Lennox-Gastaut and Dravet syndromes.

Source: https://www.news-medical.net/news/20200731/FDA-approves-CBD-oral-solution-for-treatment-of-seizures-related-to-tuberous-sclerosis-complex.aspx